Viora

Company Overview

Snapshot

Founded in August 2005, Viora operates with 51–200 employees, specializing in medical aesthetics. The company was acquired by Sinclair Pharma in February 2022, marking a significant exit in the Health Tech & Life Sciences sector.

Business overview

Viora develops noninvasive and minimally invasive products for a broad range of aesthetic treatments, including skin tightening, body and facial contouring, cellulite reduction, and hair removal. The company's technology addresses various skin conditions and aesthetic concerns, serving clinics, healthcare providers, and consumers in the medical devices and dermatology sectors globally.

Strategic signal

In February 2022, Viora was acquired by Sinclair Pharma, integrating its energy-based devices portfolio into Sinclair Pharma's operations. This acquisition signals a strategic consolidation within the medical aesthetics market, enhancing Sinclair Pharma's product offerings and providing Viora's technology with broader market reach under a larger corporate umbrella.

Company Intelligence Q&A

When was Viora acquired?

Viora was acquired by Sinclair Pharma in February 2022, and subsequently closed due to the acquisition.

What was a key product launch for Viora?

In March 2020, Viora revolutionized the laser hair removal market with the introduction of its new DioBreeze™ system.

What was a significant operational milestone for Viora in 2017?

Viora finished 2017 with record profitability and growth, demonstrating strong performance in the medical aesthetics market.

Did Viora make any acquisitions?

In August 2021, Viora announced the successful acquisition of EnerJet & AirJet Systems, expanding its product portfolio.

What was a notable partnership for Viora?

In February 2018, Viora announced a new partnership in Canada with Salient Medical Solutions, expanding its market presence.